Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.

@article{Chatterjee2012HistologicGO,
  title={Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome.},
  author={Deyali Chatterjee and Matthew H. G. Katz and Asif Rashid and Gauri R. Varadhachary and Robert A. Wolff and Hua Wang and Jeffrey E. Lee and Peter W. T. Pisters and J-N Vauthey and Christopher H. Crane and Henry F. Gomez and James L Abbruzzese and Jason Fleming and Huamin Wang},
  journal={Cancer},
  year={2012},
  volume={118 12},
  pages={3182-90}
}
BACKGROUND Several grading schemes for the extent of residual tumor in posttreatment pancreaticoduodenectomy (PD) specimens have been proposed. However, the prognostic significance of these grading schemes is unknown. METHODS Histopathologic slides of 223 cases who received neoadjuvant chemoradiation and PD were reviewed. The extent of residual tumor was graded using both the College of American Pathologists (CAP) and the Evans grading systems. The grading results were correlated with… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 38 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Protocol for the Examination of Specimens from Patients with Carcinoma of the Exocrine Pancreas

  • K Washington, J Berlin, P Branton
  • Northfield, IL: College of American Pathologists;
  • 2010
1 Excerpt

Similar Papers

Loading similar papers…